Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases

作者: John A. Hamilton , Andrew D. Cook , Paul P. Tak

DOI: 10.1038/NRD.2016.231

关键词: NoveltyInflammationMacrophageCancerGM-CSF ReceptorColony-stimulating factorBioinformaticsDrug discoveryMedicineClinical trial

摘要: Granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage (M-CSF; also known as CSF1), granulocyte (G-CSF) and interleukin-3 (IL-3) can each play a part in the host response to injury infection, there is burgeoning interest targeting these CSFs inflammatory autoimmune disorders, well cancer. For success clinical medicine, therapeutic will need be delineated from current strategies. The individual have unique biological roles, suggesting that they could used target specific conditions. This Review compares CSFs, with focus on how targeted, discusses relevant trial data summarizes potential applications of CSF. Importantly, we discuss novelty CSF biology attempt clarify some surrounding misconceptions issues affect decisions.

参考文章(264)
Seth B. Coffelt, Kelly Kersten, Chris W. Doornebal, Jorieke Weiden, Kim Vrijland, Cheei-Sing Hau, Niels J. M. Verstegen, Metamia Ciampricotti, Lukas J. A. C. Hawinkels, Jos Jonkers, Karin E. de Visser, IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature. ,vol. 522, pp. 345- 348 ,(2015) , 10.1038/NATURE14282
Jo L. Eyles, Michael J. Hickey, M. Ursula Norman, Ben A. Croker, Andrew W. Roberts, Sarah F. Drake, Will G. James, Donald Metcalf, Ian K. Campbell, Ian P. Wicks, A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood. ,vol. 112, pp. 5193- 5201 ,(2008) , 10.1182/BLOOD-2008-02-139535
Kylie A. Alexander, Ryan Flynn, Katie E. Lineburg, Rachel D. Kuns, Bianca E. Teal, Stuart D. Olver, Mary Lor, Neil C. Raffelt, Motoko Koyama, Lucie Leveque, Laetitia Le Texier, Michelle Melino, Kate A. Markey, Antiopi Varelias, Christian Engwerda, Jonathan S. Serody, Baptiste Janela, Florent Ginhoux, Andrew D. Clouston, Bruce R. Blazar, Geoffrey R. Hill, Kelli P.A. MacDonald, CSF-1–dependant donor-derived macrophages mediate chronic graft-versus-host disease Journal of Clinical Investigation. ,vol. 124, pp. 4266- 4280 ,(2014) , 10.1172/JCI75935
S.A. Robertson, C.T. Roberts, K.L. Farr, A.R. Dunn, R.F. Seamark, Fertility Impairment in Granulocyte-Macrophage Colony-Stimulating Factor-Deficient Mice Biology of Reproduction. ,vol. 60, pp. 251- 261 ,(1999) , 10.1095/BIOLREPROD60.2.251
Sayan Nandi, Mario Cioce, Yee-Guide Yeung, Edward Nieves, Lydia Tesfa, Haishan Lin, Amy W. Hsu, Robert Halenbeck, Hui-Yong Cheng, Solen Gokhan, Mark F. Mehler, E. Richard Stanley, Receptor-type Protein-tyrosine Phosphatase ζ Is a Functional Receptor for Interleukin-34 Journal of Biological Chemistry. ,vol. 288, pp. 21972- 21986 ,(2013) , 10.1074/JBC.M112.442731
Lisa T. C. Vogelpoel, Ivo S. Hansen, Theo Rispens, Femke J. M. Muller, Toni M. M. van Capel, Maureen C. Turina, Joost B. Vos, Dominique L. P. Baeten, Martien L. Kapsenberg, Esther C. de Jong, Jeroen den Dunnen, Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages Nature Communications. ,vol. 5, pp. 5444- 5444 ,(2014) , 10.1038/NCOMMS6444
Sunanda Basu, George Hodgson, Melissa Katz, Ashley R. Dunn, Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation Blood. ,vol. 100, pp. 854- 861 ,(2002) , 10.1182/BLOOD.V100.3.854
Thacyana T Carvalho, Tamires Flauzino, Eliane S Otaguiri, Ana P Batistela, Ana C Zarpelon, Thiago M Cunha, Sérgio H Ferreira, Fernando Q Cunha, Waldiceu A Verri Jr, None, Granulocyte-colony stimulating factor (G-CSF) induces mechanical hyperalgesia via spinal activation of MAP kinases and PI3K in mice. Pharmacology, Biochemistry and Behavior. ,vol. 98, pp. 188- 195 ,(2011) , 10.1016/J.PBB.2010.12.027
S J Busfield, M Biondo, M Wong, H S Ramshaw, E M Lee, S Ghosh, H Braley, C Panousis, A W Roberts, S Z He, D Thomas, L Fabri, G Vairo, R B Lock, A F Lopez, A D Nash, Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC Leukemia. ,vol. 28, pp. 2213- 2221 ,(2014) , 10.1038/LEU.2014.128